At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 1,311 enrolled
Drug / intervention
Atorvastatin calcium 10 mgdrug
Likely dose
Atorvastatin calcium 10 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Actual Use Trial In A Simulated Over-the-counter Environment Of Atorvastatin Calcium 10 Mg
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.·interventional·Posted Oct 17, 2013·Updated Feb 21, 2021
In Brief
A Phase 3 clinical trial evaluating Atorvastatin calcium 10 mg for Hypercholesterolemia. Completed, enrolled 1,311 participants across 37 sites.
Detailed Summary
The purpose of this actual use study is to simulate the over the counter use of atorvastatin calcium 10 mg.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypercholesterolemia
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartOct 2013
First PostedOct 2013
Primary CompletionDec 2014
TodayJul 2026
First PostedOct 17, 2013
Enrollment StartOct 1, 2013
Primary CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 12.7 years ago
Interventions
Atorvastatin calcium 10 mgdrug
Atorvastatin calcium 10 mg tablet to be administered orally every day